What is Entosystem?
Entosystem is at the forefront of agricultural innovation, specializing in insect farming to produce entomological proteins and flour. By utilizing food waste as a primary input, the company not only recuperates valuable nutritional content but also enhances food safety standards. This approach positions Entosystem as a key player in advancing the circular economy within the agricultural sector, transforming waste streams into high-value products.
How much funding has Entosystem raised?
Entosystem has raised a total of $58M across 1 funding round:
Other Financing Round
$58M
Other Financing Round (2024): $58M with participation from Idealist Capital, Fondaction, and Sanimax
Key Investors in Entosystem
Idealist Capital
Idealist Capital is a growth-oriented private equity firm focused on empowering change agents and reshaping industries through efficiency and waste reduction. They invest in entrepreneurs innovating for a resilient economy.
Fondaction
Fondaction is a Quebec-based retirement savings fund that invests in companies across Quebec, aiming to create and maintain quality jobs while contributing to a stronger, more equitable, and greener economy.
Sanimax
Sanimax is a BioReturn company specializing in rendering by-products into agriculture and animal nutrition products, offering collection services for various organic materials and processing them into valuable ingredients.
What's next for Entosystem?
The recent major enterprise-level funding, characterized as a strategic investment, signals a period of accelerated growth and market expansion for Entosystem. This capital is expected to fuel further development of their insect farming technologies and protein processing capabilities. The company is poised to scale its operations, reinforcing its commitment to sustainable agriculture and the efficient valorization of food waste, thereby solidifying its leadership in the burgeoning field of insect-based protein production.
See full Entosystem company page
